Parkinson's Research News
Terazocin
Exciting new research from a collaboration between Chinese
researchers and scientists at the University of Iowa has pointed towards
a clinically-available, generic drug that could be re-purposed for
Parkinson’s. |
ADHD Diagnosis Could Increase Risk for Parkinson’s
People diagnosed with attention deficit hyperactivity disorder (ADHD),
usually detected at an early age in hyperactive children, may have an
increased risk of developing Parkinson’s and Parkinson’s-like diseases, a
new study suggests. Click here to learn more about this. |
Clinical Trial Participation Guide
Clinical trials are a final and crucial step on the path to better Parkinson's disease (PD) treatments and a cure. Studies also are essential to developing ways to diagnose and even predict the disease. People with Parkinson's and their loved ones who participate in research say it allows them to take an active role in their care, advance science for themselves and future generations, and partner with PD experts at the forefront of the field. But thinking about research can bring many questions: Does every trial test a new medication, how do you find a study, who can volunteer and how? Click here to find answers to those questions and more through a comprehensive, easy-to-read guide and videos featuring people with Parkinson's and their loved ones. |
Therapies in development - Overview by Kevin McFarthing
Kevin McFarthing: “I was diagnosed with Parkinson’s in 2012. As a
scientist, I tried to find out as much as I could about the condition.
Part of that was to investigate potential therapies that may be of
benefit in the future. This resulted in an ad hoc list that needed
organizing in a spreadsheet. Following lots of collecting, the
spreadsheet below contains 200 identified projects, split into clinical
and research / pre-clinical phases. I’ve probably missed some;
I’ve undoubtedly made some mistakes. Please let me know of any
additions or corrections. In the meantime I have only one conclusion –
there really is a lot going on out there.” Click here to view the list |
New diagnostic test for Parkinson's and Lewy body dementia
NIH scientists have modified a test for early diagnosis of prion diseases with the goal of improving early diagnosis of Parkinson's disease and dementia with Lewy bodies. The group tested cerebral spinal fluid samples from people with Parkinson's disease; people with dementia with Lewy bodies; and controls, some of whom had Alzheimer's disease. The test correctly excluded all the controls and diagnosed both Parkinson's disease and dementia with Lewy bodies with 93 percent accuracy. Click here to read more |
2017 – Year in Review: A good vintage
2017 has been an incredible year for Parkinson's research. This post provides a summary of the Parkinson's-related research done in 2017. This and many more interesting posts about Parkinson's research can be found on The Science of Parkinson's Disease |